129 related articles for article (PubMed ID: 17197181)
21. A selective androgen receptor modulator for hormonal male contraception.
Chen J; Hwang DJ; Bohl CE; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2005 Feb; 312(2):546-53. PubMed ID: 15347734
[TBL] [Abstract][Full Text] [Related]
22. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L
J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661
[TBL] [Abstract][Full Text] [Related]
23. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties.
Cook CE; Kepler JA
Bioorg Med Chem Lett; 2005 Feb; 15(4):1213-6. PubMed ID: 15686944
[TBL] [Abstract][Full Text] [Related]
24. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile.
Rosen J; Negro-Vilar A
J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):222-4. PubMed ID: 15758439
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
Schlienger N; Lund BW; Pawlas J; Badalassi F; Bertozzi F; Lewinsky R; Fejzic A; Thygesen MB; Tabatabaei A; Bradley SR; Gardell LR; Piu F; Olsson R
J Med Chem; 2009 Nov; 52(22):7186-91. PubMed ID: 19856921
[TBL] [Abstract][Full Text] [Related]
26. [Hormone replacement Up-to-date. Selective androgen receptor modulators (SARMs). Current status and their future].
Tsukamoto T; Kato R; Kobayashi K
Clin Calcium; 2007 Sep; 17(9):1424-8. PubMed ID: 17767034
[TBL] [Abstract][Full Text] [Related]
27. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver.
Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
Toxicol Lett; 2006 Jun; 164(1):16-23. PubMed ID: 16356667
[TBL] [Abstract][Full Text] [Related]
28. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives.
Asano M; Hitaka T; Imada T; Yamada M; Morimoto M; Shinohara H; Hara T; Yamaoka M; Santou T; Nakayama M; Imai Y; Habuka N; Yano J; Wilson K; Fujita H; Hasuoka A
Bioorg Med Chem Lett; 2017 May; 27(9):1897-1901. PubMed ID: 28363748
[TBL] [Abstract][Full Text] [Related]
30. Discovery of diarylhydantoins as new selective androgen receptor modulators.
Nique F; Hebbe S; Peixoto C; Annoot D; Lefrançois JM; Duval E; Michoux L; Triballeau N; Lemoullec JM; Mollat P; Thauvin M; Prangé T; Minet D; Clément-Lacroix P; Robin-Jagerschmidt C; Fleury D; Guédin D; Deprez P
J Med Chem; 2012 Oct; 55(19):8225-35. PubMed ID: 22897611
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
[TBL] [Abstract][Full Text] [Related]
32. 5-Sulfonyl-benzimidazoles as selective CB2 agonists.
Verbist BM; De Cleyn MA; Surkyn M; Fraiponts E; Aerssens J; Nijsen MJ; Gijsen HJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2574-9. PubMed ID: 18394887
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
[TBL] [Abstract][Full Text] [Related]
34. Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones.
Higuchi RI; Thompson AW; Chen JH; Caferro TR; Cummings ML; Deckhut CP; Adams ME; Tegley CM; Edwards JP; López FJ; Kallel EA; Karanewsky DS; Schrader WT; Marschke KB; Zhi L
Bioorg Med Chem Lett; 2007 Oct; 17(19):5442-6. PubMed ID: 17703938
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs).
Nagata N; Miyakawa M; Amano S; Furuya K; Yamamoto N; Inoguchi K
Bioorg Med Chem Lett; 2011 Mar; 21(6):1744-7. PubMed ID: 21349712
[TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881
[TBL] [Abstract][Full Text] [Related]
37. A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate.
Akita K; Harada K; Ichihara J; Takata N; Takahashi Y; Saito K
Eur J Pharmacol; 2013 Nov; 720(1-3):107-14. PubMed ID: 24177288
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator.
Vajda EG; López FJ; Rix P; Hill R; Chen Y; Lee KJ; O'Brien Z; Chang WY; Meglasson MD; Lee YH
J Pharmacol Exp Ther; 2009 Feb; 328(2):663-70. PubMed ID: 19017848
[TBL] [Abstract][Full Text] [Related]
39. The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators.
Kim J; Wu D; Hwang DJ; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2005 Oct; 315(1):230-9. PubMed ID: 15987833
[TBL] [Abstract][Full Text] [Related]
40. Selective androgen receptor modulators for frailty and osteoporosis.
Kilbourne EJ; Moore WJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2007 Oct; 8(10):821-9. PubMed ID: 17907058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
